OPC Pharmaceutical JSC

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000OPC9
VND
23,300.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
2,16,258.39
2,72,754.15
2,36,993.66
2,10,466.41
3,37,529.00
1,94,023.09
2,18,938.33
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,16,258.39
2,72,754.15
2,36,993.66
2,10,466.41
3,37,529.00
1,94,023.09
2,18,938.33
Raw Material Cost
1,32,304.74
1,59,445.53
1,35,119.70
1,24,442.68
2,02,276.52
1,18,419.28
1,34,461.20
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
47,415.66
55,907.99
50,786.24
47,042.37
77,457.11
43,957.13
47,770.07
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
4,004.61
0.00
0.00
1,758.46
0.00
798.12
Selling and Distribution Expenses
60,622.48
73,913.48
77,311.68
56,624.80
97,332.52
47,672.31
58,390.96
Other Expenses
-4,741.57
-5,991.26
-5,078.62
-4,704.24
-7,921.56
-4,395.71
-4,856.82
Total Expenditure (Excl Depreciation)
1,92,927.22
2,33,359.02
2,12,431.39
1,81,067.48
2,99,609.04
1,66,091.59
1,92,852.15
Operating Profit (PBDIT) excl Other Income
23331.199999999997
39395.100000000006
24562.3
29398.899999999998
37920
27931.5
26086.199999999997
Other Income
1,981.33
5,946.63
3,635.49
1,213.53
2,528.73
614.88
8,458.06
Operating Profit (PBDIT)
30,650.13
50,781.32
33,567.50
36,004.94
46,032.37
34,193.84
40,025.11
Interest
0.00
4,004.61
0.00
0.00
1,758.46
0.00
798.12
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
83,953.65
1,13,308.62
1,01,873.96
86,023.73
1,35,252.47
75,603.81
84,477.13
Depreciation
5,337.62
5,439.55
5,369.74
5,392.47
5,583.69
5,647.46
5,480.88
Profit Before Tax
25,312.51
41,337.16
28,197.76
30,612.46
38,690.23
28,546.38
33,746.12
Tax
5,517.70
8,696.94
6,247.96
6,495.64
7,616.19
5,951.52
5,675.74
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
17,288.92
27,609.98
18,590.96
20,423.33
30,390.27
19,295.49
24,370.84
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
17,288.92
27,609.98
18,590.96
20,423.33
30,390.27
19,295.49
24,370.84
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
148.30
157.89
78.07
89.37
683.77
-103.22
398.80
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
17,437.22
27,767.87
18,669.04
20,512.70
31,074.04
19,192.27
24,769.64
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
Reserves
9,29,089.67
8,79,858.90
8,47,376.58
8,27,482.40
8,12,208.19
7,83,791.50
7,61,107.55
Earnings per share (EPS)
269.92
431.06
290.25
318.86
474.47
301.25
380.49
Diluted Earnings per share
269.92
431.06
290.25
318.86
474.47
301.25
380.49
Operating Profit Margin (Excl OI)
10.79%
14.44%
10.36%
13.97%
11.23%
14.4%
11.91%
Gross Profit Margin
14.17%
17.15%
14.16%
17.11%
13.12%
17.62%
17.92%
PAT Margin
7.99%
10.12%
7.84%
9.7%
9.0%
9.94%
11.13%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -20.71% vs 15.09% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is -37.20% vs 48.74% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -36.06% vs 49.79% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -100.00% vs 0.00% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Sep 2025

Compare Quarterly Results Of OPC Pharmaceutical JSC With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Net Sales
2,16,258.39
5,68,827.57
-3,52,569.18
-61.98%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,16,258.39
5,68,827.57
-3,52,569.18
-61.98%
Raw Material Cost
1,32,304.74
5,30,039.82
-3,97,735.08
-75.04%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
47,415.66
0.00
47,415.66
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
3,136.91
-3,136.91
-100.00%
Selling and Distribution Expenses
60,622.48
36,413.78
24,208.70
66.48%
Other Expenses
-4,741.57
-313.69
-4,427.88
-1,411.55%
Total Expenditure (Excl Depreciation)
1,92,927.22
5,66,453.59
-3,73,526.37
-65.94%
Operating Profit (PBDIT) excl Other Income
23,331.18
2,373.98
20,957.20
882.79%
Other Income
1,981.33
11,836.23
-9,854.90
-83.26%
Operating Profit (PBDIT)
30,650.13
20,399.54
10,250.59
50.25%
Interest
0.00
3,136.91
-3,136.91
-100.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
83,953.65
38,787.76
45,165.89
116.44%
Depreciation
5,337.62
6,189.33
-851.71
-13.76%
Profit Before Tax
25,312.51
11,073.31
14,239.20
128.59%
Tax
5,517.70
2,092.14
3,425.56
163.73%
Provisions and contingencies
0
0
0.00
Profit After Tax
17,288.92
9,047.54
8,241.38
91.09%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
17,288.92
9,047.54
8,241.38
91.09%
Share in Profit of Associates
0
0
0.00
Minority Interest
148.30
-66.38
214.68
323.41%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
17,437.22
8,981.17
8,456.05
94.15%
Equity Capital
0
0
0.00
Face Value
10,000.00
10,000.00
0.00
Reserves
9,29,089.67
10,91,472.88
-1,62,383.21
-14.88%
Earnings per share (EPS)
269.92
99.89
170.03
170.22%
Diluted Earnings per share
269.92
99.89
170.03
170.22%
Operating Profit Margin (Excl OI)
10.79%
0.42%
0.00
10.37%
Gross Profit Margin
14.17%
3.03%
0.00
11.14%
PAT Margin
7.99%
1.59%
0.00
6.40%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 21,625.84 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -20.71% vs 15.09% in Sep 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 2.75% vs -4.83% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1,743.72 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -37.20% vs 48.74% in Sep 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -14.99% vs -28.22% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2,866.88 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -36.06% vs 49.79% in Sep 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -17.60% vs -27.60% in Mar 2025

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.79%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025